Africa (WHO region) vs Israel: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Israel
100.0%
in 2024
Africa (WHO region) rank
2nd
Israel rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Israel
How they compare
Israel currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 12 shared years of data; in 2008 it was Israel ahead.
Africa (WHO region) ranks 2nd and Israel ranks 1st of 11 groups.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 68.0% | 35.0% | Israel |
| 2010s | 88.6% | 100.0% | 11.4% | Israel |
| 2020s | 93.2% | 98.2% | 5.0% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Israel?
- Israel, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Israel?
- 4.0%, with Israel ahead.
- How many years of comparable data are there for Africa (WHO region) and Israel?
- 12 years are reported by both, from 2008 to 2024.
- How do Africa (WHO region) and Israel rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Israel ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.